Pangaea Oncology Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 29, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	57	59	61	54	50	35
Market Cap Growth	-4.53%	-2.26%	12.24%	8.35%	41.34%	30.94%
Enterprise Value	59	62	63	52	40	35
Last Close Price	1.58	1.73	1.77	1.84	1.64	1.55
PS Ratio	3.39	3.55	3.62	5.44	7.49	5.27
PB Ratio	2.57	2.69	2.66	2.88	2.17	2.51
P/TBV Ratio	3.24	3.39	3.54	4.88	2.39	1.69
PEG Ratio	-	2.74	2.74	2.74	2.74	8.85
EV/Sales Ratio	3.54	3.71	3.78	5.18	6.00	5.25
Debt / Equity Ratio	0.22	0.22	0.20	0.18	0.11	0.25
Net Debt / Equity Ratio	0.08	0.08	0.00	0.03	-0.26	0.04
Net Debt / EBITDA Ratio	-0.65	-0.65	-0.04	-0.22	2.63	-2.30
Net Debt / FCF Ratio	-0.57	-0.57	-0.01	-0.22	1.65	-0.24
Asset Turnover	0.52	0.52	0.55	0.35	0.27	0.36
Inventory Turnover	3.64	3.64	4.40	5.05	5.96	3.38
Quick Ratio	1.47	1.47	1.77	1.27	4.74	2.20
Current Ratio	1.78	1.78	1.87	1.34	4.89	2.36
Return on Equity (ROE)	-15.89%	-15.89%	-5.75%	-22.89%	-14.66%	-5.73%
Return on Assets (ROA)	-7.54%	-7.54%	-4.47%	-7.52%	-6.85%	-2.12%
Return on Capital Employed (ROCE)	-15.70%	-15.70%	-8.60%	-15.90%	-10.50%	-3.60%
Earnings Yield	-6.34%	-6.05%	-1.92%	-8.59%	-5.42%	-1.81%
FCF Yield	-5.23%	-4.99%	-8.30%	-4.90%	-7.39%	-7.14%
Buyback Yield / Dilution	-19.14%	-	-	0.98%	-35.11%	-20.34%